Literature DB >> 35102489

An unbiased algorithm for objective separation of Alzheimer's, Alzheimer's mixed with cerebrovascular symptomology, and healthy controls from one another using electrovestibulography (EVestG).

Zeinab A Dastgheib1, Brian J Lithgow2, Zahra K Moussavi2.   

Abstract

Diagnosis of Alzheimer's disease (AD) from AD with cerebrovascular disease pathology (AD-CVD) is a rising challenge. Using electrovestibulography (EVestG) measured signals, we develop an automated feature extraction and selection algorithm for an unbiased identification of AD and AD-CVD from healthy controls as well as their separation from each other. EVestG signals of 24 healthy controls, 16 individuals with AD, and 13 with AD-CVD were analyzed within two separate groupings: One-versus-One and One-versus-All. A multistage feature selection process was conducted over the training dataset using linear support vector machine (SVM) classification with 10-fold cross-validation, k nearest neighbors/averaging imputation, and exhaustive search. The most frequently selected features that achieved highest classification performance were selected. 10-fold cross-validation was applied via a linear SVM classification on the entire dataset. Multivariate analysis was run to test the between population differences while controlling for the covariates. Classification accuracies of ≥ 80% and 78% were achieved for the One-versus-All classification approach and AD versus AD-CVD separation, respectively. The results also held true after controlling for the effect of covariates. AD/AD-CVD participants showed smaller/larger EVestG averaged field potential signals compared to healthy controls and AD-CVD/AD participants. These characteristics are in line with our previous study results.
© 2022. International Federation for Medical and Biological Engineering.

Entities:  

Keywords:  Alzheimer’s Disease; Cerebrovascular pathology; Classification; Electrovestibulography; Feature selection

Mesh:

Year:  2022        PMID: 35102489     DOI: 10.1007/s11517-022-02507-1

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  46 in total

Review 1.  Apoptosis in neurodegenerative disorders.

Authors:  M P Mattson
Journal:  Nat Rev Mol Cell Biol       Date:  2000-11       Impact factor: 94.444

2.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

4.  Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.

Authors:  Sreeram Krishnan; P Rani
Journal:  Biol Trace Elem Res       Date:  2014-03-30       Impact factor: 3.738

Review 5.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

6.  Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer's disease.

Authors:  Jinbiao Zhang; Jianping Jia; Wei Qin; Shuying Wang
Journal:  Neurosci Lett       Date:  2013-03-15       Impact factor: 3.046

Review 7.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

8.  Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment.

Authors:  Sung-Chun Tang; Kai-Chien Yang; Chih-Hao Chen; Shieh-Yueh Yang; Ming-Jang Chiu; Chau-Chung Wu; Jiann-Shing Jeng
Journal:  Neuromolecular Med       Date:  2018-09-21       Impact factor: 3.843

Review 9.  Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias.

Authors:  R Scott Turner; Terry Stubbs; Don A Davies; Benedict C Albensi
Journal:  Front Neurol       Date:  2020-06-05       Impact factor: 4.003

Review 10.  Global epidemiology of dementia: Alzheimer's and vascular types.

Authors:  Liara Rizzi; Idiane Rosset; Matheus Roriz-Cruz
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.